Overdosage in humans may result in a prolonged duration of action but is unlikely to be associated with acute toxic effects. Therefore, in case of overdosage no specific measures are required.
In acute toxicity studies in rodents non-specific toxic symptoms were observed after intraperitoneal administration of cetrorelix doses more than 200 times higher than the pharmacologically effective dose after subcutaneous administration.